WallStreetZenWallStreetZen

NASDAQ: INMD
Inmode Ltd Earnings Dates, Reports, Calls

OverviewForecastEarnings
RevenueDividendOwnership
Inmode earnings were $178.7M for the trailing 12 months ending Jun 30, 2025, with 39.9% growth year over year. The latest INMD earnings report on Jun 30, 2025 announced Q2 2025 earnings of $26.7M, up 46.9% from last quarter. For the last reported fiscal year 2024 ending Dec 31, 2024, INMD reported annual earnings of $181.3M, with -8.4% growth. The next INMD earnings date is Oct 29, 2025.

INMD past earnings growth

How has INMD's earnings growth performed historically?

Company
39.89%
Industry
83.78%
Market
34.44%
INMD's earnings have grown slower... subscribe to Premium to read more.
Earnings Growth vs Industry Performance
INMD's earnings have grown slower... subscribe to Premium to read more.
Earnings Growth vs Market Performance
INMD's earnings growth is accelerating... subscribe to Premium to read more.
Accelerating Earnings Growth Performance

INMD earnings history

Current Revenue
$401.6M
Current Earnings
$178.7M
Current Profit Margin
44.5%

INMD Return on Equity

Current Company
26.6%
Current Industry
15.2%
Current Market
30.7%
INMD's Return on Equity (26.6%)... subscribe to Premium to read more.
High Return on Equity Performance

INMD undefined

Current Company
23.6%
Current Industry
8.9%
INMD is generating higher Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

Be the first to know when INMD announces earnings.

INMD undefined

Current Company
22.41%
Current Industry
10.6%
INMD's ability to generate Return... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

INMD vs Medical Device Stocks

TickerEBITDAEarningsY/Y EarningsEPS
INMD$144.56M$178.70M+26.46%$2.49
IRMD$26.83M$20.66M+27.70%$1.63
SSII-$13.45M-$16.64MN/A-$0.09
TNDM-$177.78M-$205.45MN/A-$3.09
ESTA-$57.63M-$89.10MN/A-$3.11
View Top Medical Device Stocks

INMD earnings dates

Next earnings date
Oct 29, 2025

Inmode Earnings Reports & History FAQ

What were Inmode's earnings last quarter?

On INMD's earnings call on Invalid Date, Inmode (NASDAQ: INMD) reported Q2 2025 earnings per share (EPS) of $0.42, up 50% year over year. Total INMD earnings for the quarter were $26.74 million. In the same quarter last year, Inmode's earnings per share (EPS) was $0.28.

If you're new to stock investing, here's how to buy Inmode stock.

When does Inmode report earnings?

The next INMD earnings call is Invalid Date. Add INMD to your watchlist to be reminded of Inmode's next earnings date.

Is Inmode profitable or losing money?

As of the last Inmode earnings report, Inmode is currently profitable. Inmode's net profit (also called net income) for the twelve months ending Jun 30, 2025 was $178.70 million, a 19.78% increase year over year.

What was INMD's earnings growth in the past year?

As of Inmode's earnings date in Invalid Date, Inmode's earnings has grown 39.89% year over year. This is 43.89 percentage points lower than the US Medical Devices industry earnings growth rate of 83.78%. INMD earnings in the past year totalled $178.70 million.

What are Inmode's earnings expectations?

The current EPS estimate for Inmode's earnings report in Invalid Date is $0.34.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.